欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2020, Vol. 25 ›› Issue (10): 1081-1087.doi: 10.12092/j.issn.1009-2501.2020.10.001

• 基础研究 •    下一篇

锰超氧化物歧化酶模拟物对三硝基苯磺酸诱导溃疡性结肠炎大鼠的保护作用及机制研究

王艳红1,蒲君峰1,李红玲2,冯铁新3   

  1. 1甘肃省人民医院药剂科,兰州 730000,甘肃;2甘肃省人民医院肿瘤内科,兰州 730000,甘肃;3解放军总医院京中医疗区,北京 100082

  • 收稿日期:2020-02-26 修回日期:2020-08-28 出版日期:2020-10-26 发布日期:2020-11-03
  • 通讯作者: 冯铁新,男,副主任医师,研究方向:新药药理学。 Tel: 010-66780167 E-mail: 68697361@qq.com
  • 作者简介:王艳红,女,博士研究生,副主任药师,研究方向:抗炎与免疫药理学研究。 Tel: 0931-8281754 E-mail: wyh_0521@126.com
  • 基金资助:
    国家自然科学基金项目(81560498);甘肃省青年科技基金资助项目(1506RJZA170) 

Protective effect and mechanism of manganese superoxide dismutase mimic on ulcerative colitis induced by trinitrobenzene sulfonic acid in rats

WANG Yanhong 1, PU Junfeng 1, LI Hongling 2, FENG Tiexin 3   

  1. 1 Department of Pharmacy, Gansu provincial Hospital, Lanzhou 730000, Gansu, China; 2 Division of Oncology, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China; 3 Outpatient Department of Xiaoxitian, Central Medical District of Chinese PLA General Hospital, Beijing 100082, China
  • Received:2020-02-26 Revised:2020-08-28 Online:2020-10-26 Published:2020-11-03

摘要: 目的:研究锰超氧化物歧化酶模拟物(MnSODm)对2,4,6-三硝基苯磺酸(TNBS)诱导溃疡性结肠炎(UC)大鼠的保护作用及其机制。方法:Wistar大鼠随机分为:空白组、模型组、柳氮磺吡啶(SASP, 500 mg/kg)组和MnSODm低(10 mg/kg)、中(20 mg/kg)、高剂量(40 mg/kg)组。大鼠直肠给予100 mg/kg TNBS-50%乙醇溶液建立UC模型,分别用SASP及不同剂量的MnSODm对其进行治疗。连续灌胃给药7 d。观察大鼠一般情况、进行疾病活动指数(DAI)评分,取结肠标本用于评价结肠湿重指数及评估结肠组织病理学损伤程度,检测结肠组织与血清中髓过氧化物酶(MPO)活力。用试剂盒检测结肠组织中谷胱甘肽过氧化物酶(GSH-Px)和一氧化氮合酶(iNOS)活力及谷胱甘肽(GSH)和NO含量。ELISA检测大鼠结肠组织中TNF-α、IL-4及IL-10的含量。Western blot检测各组大鼠结肠黏膜中磷脂酰肌醇-3激酶(PI3K)、蛋白激酶B(AKT)及p-AKT蛋白的表达水平。结果:与模型组比较,MnSODm能改善大鼠一般状况,显著降低DAI、大鼠结肠湿重指数、病理学损伤评分及结肠组织与血清中MPO活力(P<0.05或P<0.01);此外,MnSODm 能显著降低大鼠结肠组织中iNOS、NO、TNF-α含量及PI3K、p-AKT表达水平,同时显著增加GSH-Px、GSH、IL-4和IL-10含量(P<0.05或P<0.01)。 结论:MnSODm对大鼠UC有显著的治疗作用,这种作用机制可能是通过抗氧化损伤、清除自由基、调节致炎因子和抗炎细胞因子的表达,抑制PI3K/AKT信号通路,从而阻断炎症过程实现的。

关键词: 锰超氧化物歧化酶模拟物, 2,4,6-三硝基苯磺酸, 溃疡性结肠炎, 抗炎作用, 作用机制

Abstract: AIM: To investigate the effects of manganese superoxide dismutase mimic (MnSODm) on 2, 4, 6-trinitrobenzene sulfonic acid (TNBS) induced ulcerative colitis (UC) in rats and to probe into its underlying mechanism. METHODS: Wistar rats were randomly divided into blank group, model group, sulfasalazine (SASP, 500 mg/kg) group, and different doses of MnSODm (10, 20 and 40 mg/kg) groups. Ulcerative colitis was induced in rats by rectal administration of 100 mg/kg TNBS dissolved in 50% ethanol. Rats were killed after SASP and different doses of MnSODm treatment 7 days. The disease activity index (DAI) was recorded, and then the colonic injury and inflammation were assessed by the colon weight/length ratio and microscopic damage scores. The serum and colon tissues activities myeloperoxidase (MPO) were detected by biochemistry method. The activities of glutathione peroxidase (GSH-Px), inducible nitric oxide synthase (iNOS), and the levels of glutathione (GSH) and NO in colon tissues were also detected. The levels of TNF-α, IL-4 and IL-10 in the colon tissues were measure by ELISA. Western blot was undertaken to determine the phosphorylation levels of AKT and PI3K. RESULTS: Compared with the model group, the colonic weight/length ratios, microscopic damage scores and colon tissues and serum MPO activity were significantly decreased in MnSODm groups (P<0.05 or P<0.01). INOS, NO, TNF-α, PI3K, p-AKT levels in colon tissues were also significantly decreased in MnSODm treatment groups; while the activity of GSH-Px and the concentration of GSH, IL-4 and IL-10 obviously increased (P<0.05, P<0.01). CONCLUSION: MnSODm is protective against colitis via antioxidant activity and by inhibiting inflammatory mediators and then down-regulating PI3K/AKT signaling pathways.

Key words: manganese superoxide dismutase mimic, 2, 4, 6-trinitrobenzenesulfonic acid, ulcerative colitis, antiinflammatory, mechanism

中图分类号: